Group One Trading, L.P. Acadia Pharmaceuticals Inc Transaction History

Group One Trading, L.P.

$2.54 Billion
Q4 2024

A detailed history of Group One Trading, L.P. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 5,265 shares of ACAD stock, worth $105,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,265

Previous 32,891 83.99%

Holding current value

$105,036

Previous $506,000 81.03%

% of portfolio

0.0%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $394,775 - $518,263	-27,626 Reduced 83.99%	5,265 $96,000
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $10,840 - $13,704	716 Added 2.23%	32,891 $506,000
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $282,268 - $355,634	19,307 Added 150.04%	32,175 $522,000
Q1 2024 May 10, 2024	BUY	$17.79 - $30.86 $228,921 - $397,106	12,868 New	12,868 $237,000
Q3 2023 Nov 09, 2023	BUY	$20.84 - $33.47 $3.62 Million - $5.81 Million	173,593 New	173,593 $3.62 Million
Q2 2022 Aug 11, 2022	BUY	$13.01 - $27.22 $1.15 Million - $2.4 Million	88,059 New	88,059 $1.24 Million
Q1 2022 May 12, 2022	SELL	$20.94 - $27.5 $3.81 Million - $5.01 Million	-182,133 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$16.79 - $27.09 $2.92 Million - $4.71 Million	174,022 Added 2145.51%	182,133 $4.25 Million
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $508,826 - $798,708	-32,245 Reduced 79.9%	8,111 $135,000
Q2 2021 Aug 10, 2021	SELL	$19.4 - $27.42 $920,180 - $1.3 Million	-47,432 Reduced 54.03%	40,356 $984,000
Q1 2021 May 12, 2021	BUY	$25.02 - $54.99 $1.07 Million - $2.36 Million	42,905 Added 95.59%	87,788 $2.27 Million
Q4 2020 Feb 10, 2021	SELL	$41.04 - $56.79 $1.05 Million - $1.45 Million	-25,596 Reduced 36.32%	44,883 $2.4 Million
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $1.15 Million - $1.81 Million	31,680 Added 81.65%	70,479 $2.91 Million
Q2 2020 Aug 13, 2020	SELL	$39.26 - $52.73 $1.01 Million - $1.36 Million	-25,714 Reduced 39.86%	38,799 $1.88 Million
Q1 2020 May 13, 2020	SELL	$31.65 - $46.87 $640,532 - $948,555	-20,238 Reduced 23.88%	64,513 $2.73 Million
Q4 2019 Feb 10, 2020	SELL	$36.21 - $51.4 $3.72 Million - $5.28 Million	-102,801 Reduced 54.81%	84,751 $3.63 Million
Q3 2019 Nov 12, 2019	BUY	$22.22 - $44.01 $4.17 Million - $8.25 Million	187,552 New	187,552 $6.75 Million
Q4 2018 Feb 06, 2019	SELL	$14.32 - $22.92 $727,871 - $1.17 Million	-50,829 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$13.03 - $21.81 $350,715 - $587,037	26,916 Added 112.56%	50,829 $1.06 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $877,872 - $1.3 Million	-58,253 Reduced 70.9%	23,913 $365,000
Q1 2018 May 11, 2018	SELL	$22.47 - $32.33 $1.14 Million - $1.65 Million	-50,914 Reduced 38.26%	82,166 $1.85 Million
Q4 2017 Feb 09, 2018	SELL	$26.84 - $39.14 $3.75 Million - $5.47 Million	-139,795 Reduced 51.23%	133,080 $4.01 Million
Q3 2017 Nov 15, 2017	SELL	$29.49 - $38.37 $263,375 - $342,682	-8,931 Reduced 3.17%	272,875 $10.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	281,806	281,806 $7.86 Million

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.23B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Acadia Pharmaceuticals Inc Transaction History